August 1st 2025
Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
Closing Gaps in CLL Care: Managed Care Insights and Strategies
1.5 Credit / Hematologic Cancer, Oncology
View More
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
1.0 Credit / Oncology, Hematology, Hematologic Cancer
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens
1.5 Credits / Hematologic Cancer, Hematology, Oncology
View More
Dr Sandra Stein Shares Takeaways From Banner|Aetna IVBM
January 13th 2024According to Sandra Stein, MD, of Banner Health Plans, the event highlighted the significant influence of social determinants of health on health care costs and outcomes, emphasizing the shift in focus from traditional medical care to addressing crucial factors like housing, food, transportation, and utilities for positive health outcomes.
Watch
Dr Beau Raymond Shares Expertise on Public Health, Population Well-Being
January 12th 2024Sidney (Beau) Raymond, MD, MMM, FACP, chief medical officer of Ochsner Health Network, believes that the health care system should focus on preventing illness and disease, rather than just treating them after they occur.
Watch
Top 5 Most-Read Articles From the Center of Health Equity and Access 2023
December 25th 2023The top articles of 2023 addressed key issues such as representation gaps in aRCC research, concerns about the 340B program's impact on asthma disparities, slow adoption of equity innovations, potential biases in type 2 diabetes risk models, and addressing disparities in psoriasis treatment based on race and culture.
Read More
COA's Shiela Plasencia on Improving Patient Care in Marginalized Communities
December 20th 2023Join Shiela Plasencia, director of practice support, Community Oncology Alliance (COA) as she explores improving health treatments for marginalized communities and how to apply it to the oncology population.
Watch
Understanding the Social Risk Factor Adjustment’s Effect on Star Ratings
This article examines how CMS’ adjustment for social risk factors affects the Medicare Advantage Star Ratings and the type of contracts affected by the adjustment.
Read More
Stakeholder Insights on rtCGM in T2D Population Health Management
Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.
Read More
Impact of the Patient-Centered Medical Home on Consistently High-Cost Patients
Patient-centered medical homes in Maryland’s multipayer demonstration disrupted the pattern of recurrently high expenditure among the costliest patients and improved continuity of care.
Read More
CDC Report Shows Decline in Youth Cancer Mortality, Highlights Racial and Ethnic Disparities
November 21st 2023While the overall rate of cancer death among children has declined substantially in recent decades, progress has stalled for Black and Hispanic children compared with White children since 2011.
Read More
Dr Robert Gluckman Speaks About Getting the Most Benefit From Pharmaceuticals
November 5th 2023Robert Gluckman, MD, MACP, from Providence Health Plan, discusses what he was most interested in hearing about at our Institute for Value-Based Medicine® event held in Newport Beach, California, on November 2.
Watch
Dr Jorge Garcia Addresses the Importance of Ambulatory Drug Infusion
November 4th 2023Jorge Garcia, PharmD, MS, MHA, MBA, FACHE, Baptist Health South Florida, spoke about his panel held at the recent Institute for Value-Based Medicine® that The American Journal of Managed Care® cohosted with Providence Health System.
Watch
Dr Sophia Humphreys Highlights Important Topics of Newport Beach IVBM
November 3rd 2023Sophia Humphreys, PharmD, MHA, BCBBS, discusses highlights of the Institute for Value-Based Medicine® (IVBM) event, held in partnership with Providence Health System, that recently took place in Newport Beach, California.
Watch
Private Maternal Insurance Coverage Associated With Lower Infant Mortality vs Medicaid
October 31st 2023Insurance status is known to be associated with health care access and outcomes, and a recent study found that maternal private insurance is associated with a lower infant mortality rate compared with public Medicaid insurance in the United States.
Read More
Black Patients Underrepresented in Pivotal Inflammatory Arthritis Clinical Trials
October 26th 2023While Black people are consistently underrepresented, White people are consistently overrepresented in inflammatory arthritis trials for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and juvenile idiopathic arthritis.
Read More
Communication, Teamwork Can Foster Resilience, Says Dr Lee Norman
May 14th 2023The best leaders are those who foster open communication, says Lee A. Norman, MD, MHS, MBA, who appeared at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri.
Watch
Deliberate Learning Can Help Providers Adapt, Says Dr Lee Norman
May 7th 2023Keeping up-to-date on information, whether it is about clinical matters or information systems, is critical to a deliberate learning mindset that is beneficial to health care providers, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
Watch